Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunct
- This topic has 0 replies, 1 voice, and was last updated 5 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Viewing 1 post (of 1 total)
- The forum ‘Websites’ is closed to new topics and replies.